Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: tanespimycin|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)